Sarepta International UK Ltd.

Active10987747 Private limited company

Incorporated: 29 September 2017 (9 years)
Industry: Manufacture of pharmaceutical preparations (21200)
Wholesale of pharmaceutical goods (46460)
Directors: Joseph Bratica
Owned by: Sarepta Therapeutics, Inc
Accounts type: Small
Region: South East
Address: Spaces Reading
9 Greyfriars Road
Reading
RG1 1NU

Filing status

Accounts due: 31 December 2026
Last accounts: 31 December 2024
Conf. stmt due: 26 October 2027
Last conf. stmt: 12 October 2026

Officers 1 active

Officer details are public data from the Companies House register.

Bratica, Joseph

Director · Appointed 29 September 2017

Also at Avi Biopharma International Limited

American

Born July 1963 (63)

Officer history (6 former)

30 October 2024

Resigned Standerwick, Sharon Louise as Director

1 October 2021

Resigned Genatossio, Laura as Director

14 October 2020

Appointed Genatossio, Laura as Director

5 June 2020

Resigned Gall, Matthew Garrett as Director

4 November 2019

Resigned Dolfini, Enrico Maria as Director

1 March 2019

Appointed Standerwick, Sharon Louise as Director

21 February 2019

Resigned Robertson, Andrew as Director

1 March 2018

Appointed Dolfini, Enrico Maria as Director

14 December 2017

Resigned Abreu, Heidy as Director

29 September 2017

Appointed Abreu, Heidy as Director

29 September 2017

Appointed Robertson, Andrew as Director

29 September 2017

Appointed Gall, Matthew Garrett as Director

29 September 2017

Appointed Bratica, Joseph as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Sarepta Therapeutics, Inc

Corporate entity · Notified 29 September 2017

Owns 75–100% of shares

Holds 75–100% of voting rights

Limited Company

Reg. no. 5345340

Financials

Balance sheet as at 31 December 2024 · small accounts

Cash: £2,269,079
Employees: 11

Current Ratio: 1.0x

Trend

Shareholder Funds

Balance sheet detail

	2024	2023	2022	2021	2019
Current Assets	£5,925,315	£7,847,110		£4,345,790	£1,770,719
Debtors	£3,656,236	£6,840,312		£3,237,860	£179,448
Cash	£2,269,079	£1,006,798		£1,107,930	£1,591,271
Creditors (< 1 year)	£5,710,682	£10,207,930	£8,659,555	£5,013,990	£1,686,534
Net Current Assets	£214,633	(£2,360,820)		(£668,200)	£84,185
Shareholder Funds	£214,633	(£2,360,820)		(£668,200)	£84,185